Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
SpyGlass Pharma, Inc.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Be able to understand a written informed consent and be willing to participate by evidence of signing an informed consent form
You may not be if
Planned participation in another clinical trial within 30 days of the initial study visit that, in the investigator's opinion, could confound the study results
Clareo Health | Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination
